A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology

References

• Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995;36:774–786.
   PubMed Web of Science ®Google Scholar
• Mincione F, Scozzafava A, SupuranCT. (2009). Antiglaucoma carbonic anhydrase inhibitors as ophthalomologic drugs. In: Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications;, Supuran CT; Winum JY Eds., Wiley, Hoboken (NJ), pp 139–154.
   Google Scholar
• Galassi F, Masini E, Giambene B, Fabrizi F, Uliva C, Bolla M et al. A topical nitric oxide-releasing dexamethasone derivative: effects on intraocular pressure and ocular haemodynamics in a rabbit glaucoma model. Br j Ophthalmol 2006;90:1414–1419.
   PubMed Web of Science ®Google Scholar
• Impagnatiello F, Borghi V, Gale DC, Batugo M, Guzzetta M, Brambilla S et al. A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs. Exp Eye Res 2011 (Epub ahead of print).
   Web of Science ®Google Scholar
• Krauss AH, Impagnatiello F, Toris CB, Gale DC, Prasanna G, Borghi V et al. Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating Prostaglandin F2a agonist, in preclinical models. Exp Eye Res (In Press).
   Google Scholar
• Steele RM, Benedini F, Biondi S, Borghi V, Carzaniga L, Impagnatiello F et al. Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma. Bioorg Med Chem Lett 2009;19:6565–6570.
   PubMed Web of Science ®Google Scholar
• Mincione F, Benedini F, Biondi S, Cecchi A, Temperini C, Formicola G et al. Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action. Bioorg Med Chem Lett 2011;21:3216–3221.
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. j Enzyme Inhib Med Chem 2004;19:199–229.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146–189.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–181.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467–3474.
   PubMed Web of Science ®Google Scholar
• Mincione F, Scozzafava A, Supuran CT. The development of topically acting carbonic anhydrase inhibitors as anti-glaucoma agents. Curr Top Med Chem 2007;7:849–854.
   PubMed Web of Science ®Google Scholar
• Xu Y, Chen Z, Song J. [A study of experimental carbomer glaucoma and other experimental glaucoma in rabbits]. Zhonghua Yan Ke Za Zhi 2002;38:172–175.
   PubMedGoogle Scholar
• Perrino E, Uliva C, Lanzi C, Soldato PD, Masini E, Sparatore A. New prostaglandin derivative for glaucoma treatment. Bioorg Med Chem Lett 2009;19:1639–1642.
   PubMed Web of Science ®Google Scholar
• de Leval X, Ilies M, Casini A, Dogné JM, Scozzafava A, Masini E et al. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity. j Med Chem 2004;47:2796–2804.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Menabuoni L, Mincione F, Supuran CT. Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties. j Med Chem 2002;45:1466–1476.
   PubMed Web of Science ®Google Scholar
• Sharon R. Draize test-motivations for change. Food Chem Toxicol 1985; 23:139–143.
   PubMed Web of Science ®Google Scholar
• Masini E, Nistri S, Vannacci A, Bani Sacchi T, Novelli A, Bani D. Relaxin inhibits the activation of human neutrophils: involvement of the nitric oxide pathway. Endocrinology 2004;145:1106–1112.
   PubMed Web of Science ®Google Scholar
• Bani D, Masini E, Bello MG, Bigazzi M, Sacchi TB. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 1995;55:5272–5275.
   PubMed Web of Science ®Google Scholar
• Harper JF, Brooker G. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2′0 acetylation by acetic anhydride in aqueous solution. j Cyclic Nucleotide Res 1975;1:207–218.
   PubMedGoogle Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. j Biol Chem 1971;246:2561–2573.
   PubMed Web of Science ®Google Scholar
• Davies NM, Farr SJ, Hadgraft J, Kellaway IW. Evaluation of mucoadhesive polymers in ocular drug delivery. I. Viscous solutions. Pharm Res 1991;8:1039–1043.
   PubMed Web of Science ®Google Scholar
• Vullo D, Innocenti A, Nishimori I, Pastorek J, Scozzafava A, Pastoreková S et al. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs? Bioorg Med Chem Lett 2005;15:963–969.
   PubMed Web of Science ®Google Scholar
• Liao SY, Ivanov S, Ivanova A, Ghosh S, Cote MA, Keefe K et al. Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma. j Med Genet 2003;40:257–261.
   PubMed Web of Science ®Google Scholar
• Thyelefors B, Negrel AD. The global impact of glaucoma, Bulletin of the World Health Organization, 1994.
   Google Scholar
• Koleva D. Medical costs of glaucoma and ocular hypertension in italian referral centres: a prospective study, Ophthalmologica 2007; 221: 340–347.
   PubMed Web of Science ®Google Scholar